State Street reports 5.5% stake in Altimmune
State Street Corporation reports shared beneficial ownership of 5.5% of Altimmune Inc. common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
State Street Corporation reports shared beneficial ownership of 5.5% of Altimmune Inc. common stock. The filing states 7,145,550 shares as the number of shares for which State Street has shared dispositive power, with 7,012,433 shares of shared voting power, as of 03/31/2026. The schedule identifies affiliated investment-advisory subsidiaries and is signed by Elizabeth Schaefer, Senior Vice President and Chief Accounting Officer, on 05/12/2026.
Insights
Large passive holder reports a 5.5% stake via shared voting and dispositive power.
State Street Corporation's Schedule 13G shows 7,145,550 shares of common stock where it holds shared dispositive power and 7,012,433 shares of shared voting power, as of 03/31/2026. The filing lists affiliated investment-advisory subsidiaries as the reporting entities.
This filing is typical for institutional asset managers and signals passive or index-related ownership rather than an active takeover intent. Subsequent filings would show changes in percentage or conversion to a Schedule 13D if strategy shifts.
The Schedule 13G disclosure aligns with investment-adviser reporting obligations for >5% holdings.
The form names SSGA Funds Management, State Street Global Advisors Europe Limited, and State Street Global Advisors Trust Company as related subsidiaries. Item disclosures show 0 sole voting/dispositive power and material shared powers, consistent with pooled/managed accounts.
Filing mechanics and signature by a senior officer on 05/12/2026 complete the disclosure; any future material change in ownership or intent would require an updated filing under applicable SEC rules.
Key Figures
Key Terms
Schedule 13G regulatory
Beneficial ownership regulatory
Dispositive power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does State Street report in Altimmune (ALT)?
Which State Street entities are named in the Schedule 13G for ALT?
When was the Schedule 13G for Altimmune signed?
Does this Schedule 13G indicate activist intent by State Street in ALT?
AI-generated analysis. How Rhea-AI works. Not financial advice.